|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 1.890 USD | -8.25% |
|
-8.25% | -72.33% |
| Market Cap | 32M 27.51M 25.88M 23.62M 44.08M 3.03B 44.31M 307M 119M 1.55B 120M 118M 4.93B | P/E 2024 |
-0.07x | P/E 2025 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 14.19M 12.2M 11.47M 10.47M 19.54M 1.34B 19.64M 136M 52.6M 687M 53.27M 52.11M 2.19B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
98.22% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAZ | Delayed | |
CBOE
| RNAZ | Real-time |
Last Transcript : TransCode Therapeutics, Inc.
| 1 day | -8.25% | ||
| 1 week | -8.25% | ||
| Current month | -10.00% | ||
| 1 month | -52.27% | ||
| 3 months | -62.87% | ||
| 6 months | -80.31% | ||
| Current year | -72.33% |
| 1 week | 1.88 |  | 2.27 |
| 1 month | 1.83 | | 4.26 |
| Current year | 1.83 | | 12.6 |
| 1 year | 1.83 | | 20.99 |
| 3 years | 1.83 | | 118,271.9 |
| 5 years | 1.83 | | 3,901,981.08 |
| 10 years | 1.83 | | 5,174,452.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zdravka Medarova
CTO | Chief Tech/Sci/R&D Officer | 52 | 2021-09-30 |
Philippe Calais
CEO | Chief Executive Officer | 67 | 2025-10-05 |
| Chief Executive Officer | 75 | 2024-01-12 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 2018-06-30 | |
Philippe Calais
CHM | Chairman | 67 | 2021-02-17 |
Erik Manting
BRD | Director/Board Member | 54 | 2020-12-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/3/26 | Conversion | Company | 13,834,441 | 81.7120% | ||
| 7/27/26 | Other | Company | 300,040 | 1.7722% | ||
| 6/14/24 | Free | Director | 70,000 | 1.0654% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.25% | -8.25% | -82.60% | -100.00% | 34.88M | |
| +2.02% | +1.26% | +41.37% | +105.18% | 67.82B | |
| -0.41% | -2.30% | +33.53% | +78.63% | 63.22B | |
| -1.11% | +2.78% | -14.86% | +375.59% | 27.58B | |
| -4.92% | -3.22% | -3.90% | -17.87% | 26.06B | |
| +0.45% | +0.57% | +31.49% | +15.97% | 25.38B | |
| +1.12% | +0.84% | +24.50% | -17.84% | 19.89B | |
| +6.04% | +7.25% | +233.25% | +383.12% | 17.4B | |
| -0.49% | -1.01% | -6.78% | +524.84% | 14.95B | |
| -2.27% | +1.37% | +53.01% | +160.83% | 14.62B | |
| Average | -0.73% | +0.47% | +30.90% | +150.85% | 27.7B | |
| Weighted average by Cap. | +0.21% | +0.44% | +37.66% | +140.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -16.75M -14.41M -13.55M -12.37M -23.08M -1.59B -23.2M -161M -62.13M -812M -62.92M -61.54M -2.58B | -34.66M -29.8M -28.04M -25.59M -47.75M -3.29B -48M -332M -129M -1.68B -130M -127M -5.34B |
| Net Debt | -5.77M -4.96M -4.67M -4.26M -7.95M -547M -7.99M -55.33M -21.41M -280M -21.68M -21.2M -890M | -17.81M -15.32M -14.41M -13.15M -24.54M -1.69B -24.67M -171M -66.05M -863M -66.89M -65.43M -2.75B |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | US$1.890 | -8.25% | 37,654 |
| 26-09-04 | US$2.060 | -4.41% | 10,622 |
| 26-09-03 | US$2.155 | +7.21% | 69,966 |
| 26-09-02 | US$2.010 | -2.43% | 22,514 |
| 26-09-01 | US$2.060 | -1.90% | 98,170 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- RNAZ Stock
Select your edition
All financial news and data tailored to specific country editions
